Radiation Therapy Use in Refractory and Relapsed Adolescent and Young Adult Hodgkin Lymphoma: A Report from the Children's Oncology Group

被引：1

作者：

Vega, Raymond B. Mailhot ^{[1
]}

Harker-Murray, Paul D. ^{[2
]}

Forlenza, Christopher J. ^{[3
]}

Cole, Peter ^{[4
]}

Kelly, Kara M. ^{[5
]}

Milgrom, Sarah A. ^{[6
]}

Parikh, Rahul R. ^{[7
]}

Hodgson, David C. ^{[8
]}

Castellino, Sharon M. ^{[9
]}

Kahn, Justine ^{[10
]}

Roberts, Kenneth B. ^{[11
]}

Constine, Louis S. ^{[12
]}

Hoppe, Bradford S. ^{[13
]}

机构：

[1] Univ Florida, Coll Med, Dept Radiat Oncol, Jacksonville, FL 32209 USA

[2] Med Coll Wisconsin, Dept Pediat Oncol, Milwaukee, WI USA

[3] Mem Sloan Kettering Canc Ctr, Dept Pediat Oncol, New York, NY USA

[4] Rutgers Canc Inst New Jersey, Dept Pediat, New Brunswick, NJ USA

[5] Roswell Park Canc Inst, Dept Pediat Oncol, Buffalo, NY USA

[6] Univ Colorado, Sch Med, Dept Radiat Oncol, Aurora, CO USA

[7] Rutgers Canc Inst New Jersey, Dept Radiat Oncol, New Brunswick, NJ USA

[8] Univ Hlth Network, Princess Margaret Canc Ctr, Radiat Med Program, Toronto, ON, Canada

[9] Childrens Hosp Atlanta, Atlanta, GA USA

[10] Columbia Univ, Herbert Irving Comprehens Canc Ctr, Dept Pediat Hematol Oncol, New York, NY USA

[11] Yale Sch Med, Dept Therapeut Radiol, New Haven, CT USA

[12] Univ Rochester, Med Ctr, Dept Radiat Oncol, Rochester, NY USA

[13] Mayo Clin, Dept Radiat Oncol, Jacksonville, FL USA

来源：

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2023年 / 117卷 / 02期

关键词：

STEM-CELL TRANSPLANTATION; CHEMOTHERAPY; OUTCOMES; RISK; RADIOTHERAPY; DISEASE;

D O I：

10.1016/j.ijrobp.2023.04.022

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：400 / 403

页数：4

共 16 条

[1] The Role of Radiation Therapy in Patients With Relapsed or Refractory Hodgkin Lymphoma: Guidelines From the International Lymphoma Radiation Oncology Group
Constine, Louis S.
Yahalom, Joachim
Ng, Andrea K.
Hodgson, David C.
Wirth, Andrew
Milgrom, Sarah A.
Mikhaeel, N. George
Eich, Hans Theodor
Illidge, Tim
Ricardi, Umberto
Dieckmann, Karin
Moskowitz, Craig H.
Advani, Ranjana
Mauch, Peter M.
Specht, Lena
Hoppe, Richard T.
[J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 100 (05): : 1100 - 1118
[2] Risk and Response Adapted Treatment Guidelines for Managing First Relapsed and Refractory Classical Hodgkin Lymphoma in Children and Young People. Recommendations from the EuroNet Pediatric Hodgkin Lymphoma Group
Daw, Stephen
Hasenclever, Dirk
Mascarin, Maurizio
Fernandez-Teijeiro, Ana
Balwierz, Walentyna
Beishuizen, Auke
Burnelli, Roberta
Cepelova, Michaela
Claviez, Alexander
Dieckmann, Karin
Landman-Parker, Judith
Kluge, Regine
Koerholz, Dieter
Mauz-Koerholz, Christine
Wallace, William Hamish
Leblanc, Thierry
[J]. HEMASPHERE, 2020, 4 (01):
[3] Pediatric Hodgkin Lymphoma, Version 3.2021
Flerlage, Jamie E.
Hiniker, Susan M.
Armenian, Saro
Benya, Ellen C.
Bobbey, Adam J.
Chang, Vivian
Cooper, Stacy
Coulter, Don W.
Cuglievan, Branko
Hoppe, Bradford S.
Isenalumhe, Leidy
Kelly, Kara
Kersun, Leslie
Lamble, Adam J.
Larrier, Nicole A.
Magee, Jeffrey
Oduro, Kwadwo
Pacheco, Martha
Price, Anita P.
Roberts, Kenneth B.
Smith, Christine M.
Sohani, Aliyah R.
Trovillion, Erin M.
Walling, Emily
Xavier, Ana C.
Burns, Jennifer L.
Campbell, Mallory
[J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2021, 19 (06): : 733 - 754
[4] Dose-Intensive Response-Based Chemotherapy and Radiation Therapy for Children and Adolescents With Newly Diagnosed Intermediate-Risk Hodgkin Lymphoma: A Report From the Children's Oncology Group Study AHOD0031
Friedman, Debra L.
Chen, Lu
Wolden, Suzanne
Buxton, Allen
McCarten, Kathleen
FitzGerald, Thomas J.
Kessel, Sandra
De Alarcon, Pedro A.
Chen, Allen R.
Kobrinsky, Nathan
Ehrlich, Peter
Hutchison, Robert E.
Constine, Louis S.
Schwartz, Cindy L.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (32) : 3651 - 3658
[5] Hodgkin Lymphoma, Version 2.2022 Featured Updates to the NCCN Guidelines
Hoppe, Richard T.
Advani, Ranjana H.
Ai, Weiyun Z.
Ambinder, Richard F.
Armand, Philippe
Bello, Celeste M.
Benitez, Cecil M.
Chen, Weina
Dabaja, Bouthaina
Daly, Megan E.
Gordon, Leo I.
Hansen, Neil
Herrera, Alex F.
Hochberg, Ephraim P.
Johnston, Patrick B.
Kaminski, Mark S.
Kelsey, Christopher R.
Kenkre, Vaishalee P.
Khan, Nadia
Lynch, Ryan C.
Maddocks, Kami
McConathy, Jonathan
Metzger, Monika
Morgan, David
Mulroney, Carolyn
Pullarkat, Sheeja T.
Rabinovitch, Rachel
Rosenspire, Karen C.
Seropian, Stuart
Tao, Randa
Torka, Pallawi
Winter, Jane N.
Yahalom, Joachim
Yang, Joanna C.
Burns, Jennifer L.
Campbell, Mallory
Sundar, Hema
[J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2022, 20 (04): : 323 - 334
[6] DOES THE ADDITION OF INVOLVED FIELD RADIOTHERAPY TO HIGH-DOSE CHEMOTHERAPY AND STEM CELL TRANSPLANTATION IMPROVE OUTCOMES FOR PATIENTS WITH RELAPSED/REFRACTORY HODGKIN LYMPHOMA?
Kahn, Shannon
Flowers, Christopher
Xu, Zhiheng
Esiashvili, Natia
[J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (01): : 175 - 180
[7] Response-adapted omission of radiotherapy and comparison of consolidation chemotherapy in children and adolescents with intermediate-stage and advanced-stage classical Hodgkin lymphoma (EuroNet-PHL-C1): a titration study with an open-label, embedded, multinational, non-inferiority, randomised controlled trial
Mauz-Koerholz, Christine
Landman-Parker, Judith
Balwierz, Walentyna
Ammann, Roland A.
Anderson, Richard A.
Attarbaschi, Andische
Bartelt, Jorg M.
Beishuizen, Auke
Boudjemaa, Sabah
Cepelova, Michaela
Claviez, Alexander
Daw, Stephen
Dieckmann, Karin
Fernandez-Teijeiro, Ana
Fossa, Alexander
Gattenloehner, Stefan
Georgi, Thomas
Hjalgrim, Lisa L.
Hraskova, Andrea
Karlen, Jonas
Kluge, Regine
Kurch, Lars
Leblanc, Thiery
Mann, Georg
Montravers, Francoise
Pears, Jean
Pelz, Tanja
Rajic, Vladan
Ramsay, Alan D.
Stoevesandt, Dietrich
Uyttebroeck, Anne
Vordermark, Dirk
Koerholz, Dieter
Hasenclever, Dirk
Wallace, William Hamish
[J]. LANCET ONCOLOGY, 2022, 23 (01) : 125 - 137
[8] Excellent Outcome for Pediatric Patients With High-Risk Hodgkin Lymphoma Treated With Brentuximab Vedotin and Risk-Adapted Residual Node Radiation
Metzger, Monika L.
Link, Michael P.
Billett, Amy L.
Flerlage, Jamie
Lucas, John T., Jr.
Mandrell, Belinda N.
Ehrhardt, Matthew J.
Bhakta, Nickhill
Yock, Torunn, I
Friedmann, Alison M.
de Alarcon, Pedro
Luna-Fineman, Sandra
Larsen, Eric
Kaste, Sue C.
Shulkin, Barry
Lu, Zhaohua
Li, Chen
Hiniker, Susan M.
Donaldson, Sarah S.
Hudson, Melissa M.
Krasin, Matthew J.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (20) : 2276 - +
[9] Brentuximab vedotin as consolidation therapy after autologous stem-cell transplantation in patients with Hodgkin's lymphoma at risk of relapse or progression (AETHERA): a randomised, double-blind, placebo-controlled, phase 3 trial
Moskowitz, Craig H.
Nademanee, Auayporn
Masszi, Tamas
Agura, Edward
Holowiecki, Jerzy
Abidi, Muneer H.
Chen, Andy I.
Stiff, Patrick
Gianni, Alessandro M.
Carella, Angelo
Osmanov, Dzhelil
Bachanova, Veronika
Sweetenham, John
Sureda, Anna
Huebner, Dirk
Sievers, Eric L.
Chi, Andy
Larsen, Emily K.
Hunder, Naomi N.
Walewski, Jan
[J]. LANCET, 2015, 385 (9980) : 1853 - 1862
[10] Targeted radiotherapy for early-stage, low-risk pediatric Hodgkin lymphoma slow early responders: a COG AHOD0431 analysis
Parekh, Akash
Keller, Frank G.
McCarten, Kathleen M.
Kessel, Sandy
Cho, Steve
Pei, Qinglin
Wu, Yue
Castellino, Sharon M.
Constine, Louis S.
Schwartz, Cindy L.
Hodgson, David
Kelly, Kara M.
Hoppe, Bradford S.
[J]. BLOOD, 2022, 140 (10) : 1086 - 1093

← 1 2 →